About this trial
This is a single-center, prospective, observational cohort study designed to investigate the progression and differential diagnosis of Parkinsonism using a multimodal approach. The study plans to enroll 400 patients with Parkinsonism, 120 patients with rapid eye movement sleep behavior disorder, and 120 healthy controls, with follow-up for 5 years.
Assessments will include neuroimaging, clinical rating scales, biological samples, blood flow evaluation, neurophysiological testing, tremor analysis, and voice and video assessments. The study aims to characterize disease progression, explore factors associated with progression from rapid eye movement sleep behavior disorder to Parkinsonism, and improve the ability to distinguish among different Parkinsonian disorders.
Eligibility criteria
Qualifiers
Meets the diagnostic criteria for rapid eye movement sleep behavior disorder established by the American Academy of Sleep Medicine
Chinese citizen
Age >30 years and <80 years
Able to understand the study, show good compliance, and provide written informed consent personally or through a legal representative
Disqualifiers
Significant cognitive impairment (MMSE ≤23)
Unable to sign the informed consent form or unable to complete study procedures for other reasons
Any other condition that, in the opinion of the investigator, makes the participant unsuitable for this study
Trial design
Treatments tested in this trial
- Not listed